Clinical trial
Israel Multicenter D-Serine Study (IMSER) for the Treatment of Schizophrenia
NCT00138775 · Sheba Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00138775 |
|---|---|
| Title | Israel Multicenter D-Serine Study (IMSER) for the Treatment of Schizophrenia |
| Official title | D-Serine Adjuvant Pharmacotherapy for the Treatment of Schizophrenia |
| Lead sponsor | Sheba Medical Center, Other |
| Collaborators | Stanley Medical Research Institute |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder |
| Intervention type | Drug |
| Interventions | D-serine |
| Enrollment | 200 |
| Start date | Oct 1, 2004 |
| Completion | Oct 1, 2007 |
| First posted | Aug 30, 2005 |
| Last update posted | Dec 27, 2006 |
| Countries | Israel |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: